KR20230047985A - Sunscreen composition comprising polyglyceryl surfactants - Google Patents
Sunscreen composition comprising polyglyceryl surfactants Download PDFInfo
- Publication number
- KR20230047985A KR20230047985A KR1020230040060A KR20230040060A KR20230047985A KR 20230047985 A KR20230047985 A KR 20230047985A KR 1020230040060 A KR1020230040060 A KR 1020230040060A KR 20230040060 A KR20230040060 A KR 20230040060A KR 20230047985 A KR20230047985 A KR 20230047985A
- Authority
- KR
- South Korea
- Prior art keywords
- sunscreen
- cosmetic composition
- polyglyceryl
- peg
- surfactant
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 59
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 55
- 239000004094 surface-active agent Substances 0.000 title claims abstract description 13
- 239000002537 cosmetic Substances 0.000 claims abstract description 40
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 13
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 8
- 229940008099 dimethicone Drugs 0.000 claims description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 7
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 claims description 5
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 4
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 4
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 4
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 4
- 229960001679 octinoxate Drugs 0.000 claims description 4
- 239000004408 titanium dioxide Substances 0.000 claims description 4
- 239000011787 zinc oxide Substances 0.000 claims description 4
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 3
- 229960005193 avobenzone Drugs 0.000 claims description 3
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims description 3
- 229960000655 ensulizole Drugs 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 3
- 229960000601 octocrylene Drugs 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 claims description 3
- 229960003656 ricinoleic acid Drugs 0.000 claims description 3
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 claims description 3
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 claims description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical group OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 2
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 claims description 2
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 claims description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 claims description 2
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 claims description 2
- 229960004697 enzacamene Drugs 0.000 claims description 2
- 229960004881 homosalate Drugs 0.000 claims description 2
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 claims description 2
- 229960002248 meradimate Drugs 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 2
- 229960001173 oxybenzone Drugs 0.000 claims description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 claims description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 claims 1
- 229940116224 behenate Drugs 0.000 claims 1
- 230000000903 blocking effect Effects 0.000 claims 1
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract description 13
- 230000000052 comparative effect Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000012071 phase Substances 0.000 description 6
- 238000005191 phase separation Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 208000000453 Skin Neoplasms Diseases 0.000 description 3
- 201000000849 skin cancer Diseases 0.000 description 3
- 206010014970 Ephelides Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000036561 sun exposure Effects 0.000 description 2
- 230000037072 sun protection Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- TYRYZLMVZZMQDR-UHFFFAOYSA-N 2-[1,1-bis(2H-benzotriazol-4-yl)-2-methylidenebutyl]-3,4,5,6-tetramethylphenol Chemical compound C=C(C(C1=C(C(=C(C(=C1C)C)C)C)O)(C1=CC=CC=2NN=NC=21)C1=CC=CC=2NN=NC=21)CC TYRYZLMVZZMQDR-UHFFFAOYSA-N 0.000 description 1
- MGGDNLOBWVBWRA-UHFFFAOYSA-N C1=CC=C(C=C1)C(=O)CCCCCCC2=C(C=CC(=C2O)N)C(=O)O Chemical compound C1=CC=C(C=C1)C(=O)CCCCCCC2=C(C=CC(=C2O)N)C(=O)O MGGDNLOBWVBWRA-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- -1 bis-ethylhexyloxy Chemical group 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 자외선 차단용 화장료 조성물에 관한 것으로, 더욱 상세하게는 상분리 없이 뛰어난 안정성을 가지며, 발림성이 우수하고 피부 건조함이 개선된 유중수형 자외선 차단용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for sunscreen, and more particularly, to a water-in-oil type sunscreen cosmetic composition that has excellent stability without phase separation, excellent spreadability, and improved skin dryness.
태양광으로부터 조사되는 자외선은 피부에 홍반이나, 부종, 주근깨, 피부암을 일으키는 주요한 원인으로 작용하여, 최근 자외선에 기인한 여러 가지 피부 질병들에 대한 많은 연구가 활발히 진행되고 있다. 일반적으로 자외선은 그 파장에 따라, 200-280 nm의 파장은 UV-C, 280-320 nm의 파장은 UV-B, 320-400 nm의 파장은 UV-A로 분류된다. UV-C는 오존층을 통과하면서 지표면에 도달하지 못하고 소실되며, UV-B는 피부의 표피까지 침투되어 홍 반과 주근깨, 부종 등을 일으킨다. UV-A는 피부의 진피까지 침투하여 피부암과 주름, 멜라닌 형성을 촉진하는 등, 피부 노화 및 피부 자극을 유발하는 것으로 알려져 있다. 다수의 역학 연구로 일광 노출과 인체 피부암의 강력한 관계가 증명되어 있으며, 자세한 관계가 토의되기도 하였다(DeSimone, 'Sunscreen and Suntan Products', Handbook of Nonpre-scription Drugs, 7th Ed., Chapter 26, pp499-511, American Pharmaceutical Association, Washington, D.C.;1982).Ultraviolet rays irradiated from sunlight act as a major cause of skin erythema, edema, freckles, and skin cancer, and many studies on various skin diseases caused by ultraviolet rays have been actively conducted recently. In general, ultraviolet rays are classified according to their wavelengths: UV-C for wavelengths of 200-280 nm, UV-B for wavelengths of 280-320 nm, and UV-A for wavelengths of 320-400 nm. UV-C passes through the ozone layer and is lost without reaching the ground surface, while UV-B penetrates into the epidermis and causes erythema, freckles, and swelling. UV-A is known to cause skin aging and skin irritation, such as penetrating into the dermis of the skin and promoting skin cancer, wrinkles, and melanin formation. A number of epidemiological studies have demonstrated a strong relationship between sun exposure and human skin cancer, and the detailed relationship has been discussed (DeSimone, 'Sunscreen and Suntan Products', Handbook of Nonpre-scription Drugs, 7th Ed., Chapter 26, pp499- 511, American Pharmaceutical Association, Washington, D.C.; 1982).
일광 노출과 관련된 상기 언급된 위험의 결과로, 자외선 차단 제품에 대한 일반 대중의 관심은 증가하여 왔으며, 그 결과 다양한 종류의 SPF(자외선 차단지수)를 가지는 자외선 차단 제품이 출시되고 있다. 자외선 차단 제품은 높은 SPF값을 갖도록 하기 위해 이산화티탄, 산화아연 등의 무기 자외선 차단제 또는 에칠헥실메톡시신나메이트, 에칠헥실살리실레이트, 옥토크릴렌, 부틸메톡시디벤조일메탄, 비스-에칠헥실옥시페놀메톡시페닐트리아진 및 디에칠아미노하이드록시벤조일헥실벤조에이트 등의 유기 자외선 차단제를 포함한다. As a result of the above-mentioned risks associated with sun exposure, the general public's interest in sunscreen products has increased, and as a result, sunscreen products with various types of sun protection factors (SPFs) are on the market. Sunscreen products contain inorganic sunscreens such as titanium dioxide and zinc oxide, or ethylhexylmethoxycinnamate, ethylhexylsalicylate, octocrylene, butylmethoxydibenzoylmethane, and bis-ethylhexyloxy to have a high SPF value. and organic sunscreens such as phenolmethoxyphenyltriazine and diethylaminohydroxybenzoylhexylbenzoate.
또한 제품의 제조방법에 따라, 수중유(Oil in water, O/W)형 유화형 자외선 차단용 화장료와 유중수(Water in oil, W/O)형 자외선 차단용 화장료로 나누어진다. 수중유형 자외선차단 화장료의 촉촉하고 가벼운 사용감으로 사용이 용이하지만, 땀이나 물에는 쉽게 지워질 수 있는 것이 특징이고, 유중수형 자외선 차단용 화장료의 경우 땀이나 물에 강하여 오래 지속되는 효과는 있으나, 그 특성 상 세안 시 쉽게 지워지지 않고, 무겁고 답답한 사용감이 특징이다. In addition, depending on the manufacturing method of the product, it is divided into oil in water (O/W) type emulsified sunscreen cosmetics and water in oil (W/O) type sunscreen cosmetics. Water-in-oil sunscreen cosmetics are easy to use due to their moist and light feel, but are characterized by being easily erased by sweat or water. It is not easily erased when washing the face, and it is characterized by a heavy and stuffy feeling.
이러한 무겁고 답답한 사용감을 가볍게 조절하기 위해 유중수형 화장료의 경우 내상인 수상의 비를 높이게 된다. 그리고 제형의 특성 상 안정성이 떨어지므로, 그것을 해결하기 위해 고점도를 유지하게 되는데 이로 인해 더욱더 사용감이 무거워지게 돼, 사용감에 한계가 나타나게 된다.In order to lightly control this heavy and stuffy feeling of use, in the case of water-in-oil cosmetics, the ratio of the water phase, which is the internal phase, is increased. In addition, since stability is low due to the nature of the formulation, high viscosity is maintained to solve this problem, which makes the feeling of use heavier and limits the feeling of use.
그로 인해 내상인 수상의 양이 많아도 안정하면서도 점도를 낮게 유지할 수록 기존 W/O의 특징을 가지면서 우수한 사용감이 나타날 수 있다.As a result, even if the amount of the aqueous phase, which is the internal phase, is stable and the viscosity is kept low, an excellent feeling of use may appear while having the characteristics of the existing W / O.
한편 종래 한국 등록 특허 10-2011-0012942는 무기 자외선 차단제의 뭉침 현상을 개선한 자외선 차단용 화장료 조성물을 개시하고 있으나, 화장료 조성물 내에서 분산성을 높일 수는 있으나, 상분리 등과 같은 문제점이 확인되었으며, 안정성을 개선하는데는 미흡하였다. On the other hand, conventional Korean Patent No. 10-2011-0012942 discloses a cosmetic composition for sunscreen with improved aggregation of inorganic sunscreen, but it is possible to increase dispersibility in the cosmetic composition, but problems such as phase separation have been identified, It was insufficient to improve stability.
따라서 본 발명은 위와 같은 문제점을 해결하고, 상분리없고, 안정성이 우수한 유무기 복합 자외선 차단용 조성물을 제공하고자 한다. Therefore, the present invention is to solve the above problems, to provide an organic-inorganic composite sunscreen composition with excellent stability without phase separation.
또한 본 발명은 발림성이 우수하고, 사용감이 뛰어난 자외선 차단용 화장료 조성물을 제공하고자 한다.In addition, the present invention is to provide a cosmetic composition for sunscreen with excellent application properties and excellent feeling of use.
상기 과제를 해결하기 위하여, 본 발명은 폴리글리세릴 계열의 계면활성제 및 비이온 계면활성제를 포함하며, 무기 자외선 차단제 및 유기 자외선 차단제를 포함하는, 자외선 차단용 화장료 조성물을 제공한다. In order to solve the above problems, the present invention provides a cosmetic composition for sunscreen, including a polyglyceryl-based surfactant and a nonionic surfactant, and including an inorganic sunscreen agent and an organic sunscreen agent.
본 발명의 발명자들은 높은 자외선 차단 지수를 갖는 W/O 형 자외선 차단용 화장료의 경우 땀이나 물에 강하여 오래 지속되는 효과는 있으나, 그 특성상 세안 시 쉽게 지워지지 않고, 무겁고 답답한 사용감이 문제가 되었다. 이러한 무겁고 답답한 사용감을 가볍게 조절하기 위해 수상의 비를 높이게 되는데, 이 경우 제형의 안정성이 저해된다는 문제가 발생하게 되었다. The inventors of the present invention have a long-lasting effect because they are resistant to sweat or water in the case of W / O type sunscreen cosmetics having a high sun protection index, but due to their characteristics, they are not easily erased during face washing, and the feeling of heavy and stuffy use has become a problem. In order to lightly control this heavy and stuffy feeling of use, the ratio of the water phase is increased, but in this case, the problem that the stability of the formulation is impaired has occurred.
화장료 조성물의 안정성을 높이기 위하여 왁스류나 겔화제를 사용하게 되는 경우 이로 인해 사용감이 좋지 않고, 가벼운 사용감을 나타내기에는 한계가 있어 업계에서는 화장료 조성물의 안정성이 우수하면서도 가벼운 사용감을 나타낼 수 있는 방안에 대해 오랜 시간 연구하였다. 그 결과 본 발명의 발명자들은 유무기 자외선 차단제가 혼합된 자외선 차단용 조성물에 폴리글리세릴 계열의 계면활성제와 비이온계면활성제를 혼합하여 사용하는 경우, 사용감이 우수하면서도 화장료 조성물의 안정성이 뛰어나다는 것을 확인하고 본 발명을 완성하게 되었다. When waxes or gelling agents are used to increase the stability of the cosmetic composition, the feeling of use is not good and there is a limit to showing a light feeling of use. studied for a long time. As a result, the inventors of the present invention found that when a polyglyceryl-based surfactant and a nonionic surfactant are mixed and used in a sunscreen composition in which an organic and inorganic sunscreen agent is mixed, the stability of the cosmetic composition is excellent while the feeling of use is excellent. confirmed and completed the present invention.
본 발명의 발명자들은 특히 폴리글리세릴 계열의 계면활성제 중에서 특히 리시놀레익애씨드의 폴리머와 폴리글리세린류의 복합 에스터인 폴리글리세릴-3 폴리리시놀리에이트를 피이지-30 디폴리하이드록시스테아레이트 등의 비이온계 계면활성제와 함께 사용하는 경우, 점도가 낮아 사용감이 우수하면서도 무기 자외선 차단제의 상분리 없이 안정성이 뛰어난 자외선 차단용 화장료 조성물을 얻을 수 있다는 놀라운 사실을 확인하고 본 발명을 완성하게 되었다.In particular, the inventors of the present invention used polyglyceryl-3 polyricinoleate, which is a complex ester of a polymer of ricinoleic acid and polyglycerols, among polyglyceryl-based surfactants, such as PEG-30 dipolyhydroxystearate and the like. The present invention was completed after confirming the surprising fact that, when used with a nonionic surfactant of , a cosmetic composition for sunscreen with excellent stability without phase separation of inorganic sunscreens with excellent feeling of use due to low viscosity can be obtained.
상기 폴리글리세릴 계열의 계면활성제는 추가로, 폴리글리세릴-2세스퀴이소스테아레이트, 폴리글리세릴-2트리이소스테아레이트, 폴리글리세릴-3메칠글루코오스디스테아레이트, 폴리글리세릴-6스테아레이트, 폴리글리세릴-6베헤네이트 및 폴리글리세릴-6폴리리시놀리에이트로 이루어진 군에서 선택된 어느 하나 이상을 사용할 수 있다.The polyglyceryl-based surfactant may further include polyglyceryl-2sesquiisostearate, polyglyceryl-2triisostearate, polyglyceryl-3methylglucose distearate, and polyglyceryl-6 stearate. At least one selected from the group consisting of late, polyglyceryl-6behenate, and polyglyceryl-6polyricinoleate may be used.
본 발명의 발명자들은 상기 폴리글리세릴 계열의 계면활성제와 함께 비이온 계면활성제를 사용하는 경우, 본 발명의 목적을 달성하는데 효과적이라는 사실을 확인하고 본 발명을 완성하게 되었다. The inventors of the present invention have completed the present invention after confirming that the use of a nonionic surfactant together with the polyglyceryl surfactant is effective in achieving the object of the present invention.
즉, 본 발명의 발명자들은 비이온 계면활성제를 함께 사용할 때, 자외선 차단용 조성물의 발림성이 뛰어나면서도 상분리가 없는 안정성이 우수한 화장료 조성물을 제조할 수 있다는 것을 확인하게 되었다. That is, the inventors of the present invention have confirmed that when a nonionic surfactant is used together, a cosmetic composition with excellent spreadability of the sunscreen composition and excellent stability without phase separation can be prepared.
본 발명의 자외선 차단용 화장료 조성물은 상기 비이온 계면활성제를 포함하며, 상기 비이온 계면활성제는 소르비탄세스퀴올리에이트, 피이지-9폴리디메칠실록시에칠디메치콘, 피이지-10디메치콘, 피이지-30 디폴리하이드록시스테아레이트, 세틸피이지/피피지-10/1디메치콘, 라우릴피이지-9 폴리디메칠실록시에칠디메치콘, 및 세틸피이지/피피지-10/1디메치콘으로 이루어진 군에서 선택된 어느 하나 이상을 포함할 수 있으며, 바람직하게는 세틸피이지/피피지-10/1디메치콘, 가장 바람직하게는 피이지-30 디폴리하이드록시스테아레이트이 이용될 수 있다.The cosmetic composition for sunscreen of the present invention includes the nonionic surfactant, and the nonionic surfactant includes sorbitan sesquioleate, PEG-9 polydimethylsiloxyethyldimethicone, and PEG-10 dimethicone. Chicon, PEG-30 Dipolyhydroxystearate, CetylPG/PPG-10/1 Dimethicone, LaurylPG-9 Polydimethylsiloxyethyldimethicone, and CetylPG/PPG- It may contain at least one selected from the group consisting of 10/1 dimethicone, preferably cetyl PG/PPG-10/1 dimethicone, and most preferably PEG-30 dipolyhydroxystearate. It can be.
상기 무기 자외선 차단제는 티타늄디옥사이드 및 징크옥사이드로 이루어진 군에서 선택된 어느 하나 이상이 이용될 수 있다. The inorganic sunscreen may use at least one selected from the group consisting of titanium dioxide and zinc oxide.
상기 유기 자외선 차단제는 에칠헥실메톡시신나메이트, 에칠헥실살리실레이트, 옥토크릴렌, 부틸메톡시디벤조일메탄, 옥시벤존, 옥틸트리아존, 멘틸안트라닐레이트, 메칠렌비스-벤조트리아졸릴테트라메칠부틸페놀, 호모살레이트, 에칠헥실트리아존, 3,4-메틸벤질리덴 켐퍼, 이소아밀-p-메톡시신나메이트, 비스-에틸헥실옥시페놀메톡시페닐트리아진, 폴리실리콘-15, 디에칠아미노하이드록시벤조일헥실벤조에이트, 및 페닐벤즈이미다졸설포닉애씨드로 이루어진 군에서 선택된 어느 하나 이상일 수 있다. The organic sunscreen agent is ethylhexylmethoxycinnamate, ethylhexylsalicylate, octocrylene, butylmethoxydibenzoylmethane, oxybenzone, octyltriazone, menthylanthranilate, methylenbis-benzotriazolyltetramethyl Butylphenol, homosalate, ethylhexyltriazone, 3,4-methylbenzylidene camphor, isoamyl-p-methoxycinnamate, bis-ethylhexyloxyphenolmethoxyphenyltriazine, polysilicon-15, diethyl It may be at least one selected from the group consisting of aminohydroxybenzoylhexylbenzoate, and phenylbenzimidazolesulfonic acid.
상기 폴리글리세릴계의 계면활성제는 화장료 조성물 전체 중량 대비 0.3 내지 5 중량% 포함될 수 있으며, 바람직하게는 0.5 내지 4 중량%, 더욱 바람직하게는 0.8 내지 2.5 중량% 포함될 수 있다. 상기 범위 미만일 경우, 제형의 점도가 높아지고 분리가 일어나는 문제가 있을 수 있으며, 상기 범위를 초과하는 경우 제형 안정성에 문제가 있을 수 있다. The polyglyceryl-based surfactant may be included in an amount of 0.3 to 5% by weight, preferably 0.5 to 4% by weight, more preferably 0.8 to 2.5% by weight based on the total weight of the cosmetic composition. If it is less than the above range, there may be a problem in that the viscosity of the formulation increases and separation occurs, and if it exceeds the above range, there may be a problem with formulation stability.
상기 비이온계 계면활성제는 화장료 조성물 전체 중량 대비 0.5 내지 10 중량% 포함될 수 있으며, 바람직하게는 1 내지 7 중량%, 더욱 바람직하게는 1.5 내지 6 중량% 포함될 수 있다. 상기 범위 미만일 경우, 유화가 제대로 이루어지지 않아 분리가 일어나는 문제가 있을 수 있으며, 상기 범위를 초과하는 경우 점도를 높이고 유화 안정성에 문제가 있을 수 있다.The nonionic surfactant may be included in an amount of 0.5 to 10% by weight, preferably 1 to 7% by weight, more preferably 1.5 to 6% by weight, based on the total weight of the cosmetic composition. If it is less than the above range, there may be a problem in which separation occurs due to poor emulsification, and if it exceeds the above range, viscosity may increase and there may be a problem in emulsion stability.
상기 무기 자외선 차단제는 화장료 조성물 전체 중량 대비 2 내지 30 중량% 포함될 수 있으며, 바람직하게는 3 내지 25 중량%, 더욱 바람직하게는 5 내지 20 중량% 포함될 수 있다. 상기 범위 미만일 경우, 자외선 차단 효과가 미비한 문제가 있을 수 있으며, 상기 범위를 초과하는 경우 제형 내 분산이 되지 않고, 제형 안정성에 문제가 있을 수 있다.The inorganic sunscreen may be included in 2 to 30% by weight, preferably 3 to 25% by weight, more preferably 5 to 20% by weight, based on the total weight of the cosmetic composition. If it is less than the above range, there may be a problem of insufficient sunscreen effect, and if it exceeds the above range, dispersion in the formulation may not occur and there may be a problem with formulation stability.
상기 유기 자외선 차단제는 화장료 조성물 전체 중량 대비 1 내지 30 중량% 포함될 수 있으며, 바람직하게는 3 내지 25 중량%, 더욱 바람직하게는 5 내지 20 중량% 포함될 수 있다. 상기 범위 미만일 경우, 자외선 차단효과가 떨어지는 문제가 있을 수 있으며, 상기 범위를 초과하는 경우 피부 자극 및 제형 안정성에 문제가 있을 수 있다.The organic sunscreen may be included in an amount of 1 to 30% by weight, preferably 3 to 25% by weight, more preferably 5 to 20% by weight, based on the total weight of the cosmetic composition. If it is less than the above range, there may be a problem in that the sunscreen effect is lowered, and if it exceeds the above range, there may be problems with skin irritation and formulation stability.
본 발명의 자외선 차단용 조성물을 제조하는 방법은 업계에서 파우더 상태의 유기 자외선 차단제와 무기 자외선 차단제를 포함하는 자외선 차단제용 조성물을 제조하는 통상적인 방법으로 제조할 수 있다. The method for preparing the sunscreen composition of the present invention can be prepared by a conventional method in the industry for preparing a sunscreen composition comprising an organic sunscreen agent and an inorganic sunscreen agent in powder form.
또한, 본 발명의 일 실시예에 따른 자외선 차단용 화장료 조성물의 피부 도포량은 피부의 상태, 피부의 자외선에 대한 반응 정도, 자외선 지수 등에 따라 다양하게 선택될 수 있다. 도포는 하루에 한번 바를 수도 있고, 수회 나누어 바를 수도 있다. In addition, the skin application amount of the sunscreen cosmetic composition according to an embodiment of the present invention may be variously selected depending on the condition of the skin, the degree of reaction of the skin to ultraviolet rays, the ultraviolet index, and the like. The application may be applied once a day or divided several times.
상술한 바와 같은 본 발명의 일 실시예에 따른 자외선 차단용 화장료 조성물의 제형은 특별히 한정되지 않는다.The dosage form of the cosmetic composition for sunscreen according to an embodiment of the present invention as described above is not particularly limited.
본 발명의 자외선 차단용 조성물은 상분리없이 뛰어난 안정성을 제공한다.The sunscreen composition of the present invention provides excellent stability without phase separation.
또한 본 발명은 발림성이 우수하고, 사용감이 뛰어난 자외선 차단용 화장료 조성물을 제공한다. In addition, the present invention provides a cosmetic composition for sunscreen with excellent application properties and excellent feeling of use.
이하, 본 발명을 보다 구체적으로 설명하기 위하여 하기 실시예 등을 들어 설명한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며 본 발명의 범위가 아래에서 상술하는 실시예들에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예들은 본 발명의 구체적 이해를 돕기 위해 예시적으로 제공되는 것이다.Hereinafter, the following examples and the like will be described in order to explain the present invention in more detail. However, embodiments according to the present invention can be modified in many different forms, and the scope of the present invention should not be construed as being limited to the embodiments described below. Embodiments of the present invention are provided by way of example to help a detailed understanding of the present invention.
<유화제에 따른 화장품 제조 실시예><Example of manufacturing cosmetics according to emulsifier>
하기 표 1의 조성을 갖는 자외선 차단용 조성물을 다음과 같은 방법으로 제조하였다. 하기 성분들의 단위는 중량%로 나타내었다.A sunscreen composition having the composition shown in Table 1 below was prepared in the following manner. The units of the following components are expressed in % by weight.
1) 상기 Part A 및 B의 C의 원료를 각각 계량한다.1) Weigh the raw materials of C of Part A and B, respectively.
2) Part B를 70 - 75℃로 가온하며 교반한 후, Part A를 투입, 혼합하여 균일상으로 만든다.2) After heating and stirring Part B to 70 - 75℃, add Part A and mix to make a homogeneous phase.
3) Part C를 70 - 75℃로 가온하며 교반하여 균일상으로 만든다.3) Heat Part C to 70 - 75℃ and stir to make a homogeneous phase.
4) Part A가 충분히 분산된 Part B에 Part C를 서서히 투입하여 교반하여 유화하였다.4) Part C was slowly added to Part B, where Part A was sufficiently dispersed, and stirred to emulsify.
<실험예 1. 실시예와 비교예의 점도 변화 및 제형 안정성 비교><Experimental Example 1. Comparison of viscosity change and formulation stability between Examples and Comparative Examples>
상기 표 1의 조성을 갖는 실시예와 비교예의 점도 변화와 제형 안정성을 비교하여 하기 표 2 및 표 3에 나타냈다. Viscosity change and formulation stability of Examples having the compositions of Table 1 and Comparative Examples were compared and shown in Tables 2 and 3 below.
하기 표 2의 점도 변화는 실시예와 비교예의 조성을 갖는 화장료 조성물을 25 ℃에서 브룩필드 점도계(Brookfield LVT), 스핀들 4로 측정하여 나타내었다. Viscosity changes in Table 2 below are shown by measuring the cosmetic compositions having the compositions of Examples and Comparative Examples at 25 ° C. using a Brookfield LVT (Brookfield LVT) spindle 4.
하기 표 3은 온도에 따른 실시예와 비교예의 제형 안정성을 확인한 결과를 나타낸 것이다.Table 3 below shows the results of confirming the formulation stability of Examples and Comparative Examples according to temperature.
유화시스템에 따른 제형의 안정성을 확인하기 위해, 나머지 함량은 고정하고 polyglyceryl계 계면활성제를 적용여부로 실험을 실시하였다. 그 결과 실시예와 비교예의 1일차 점도를 확인한 결과 실시예가 더 낮은 점도임에도 불구하고 각 경시에 따른 제형 안정성을 확인해 본 결과 실시예는 안정하나 비교예는 상층분에 오일과 무기 자외선 차단제가 분리되는 현상이 발견되었다. 이처럼 실시예의 경우는 낮은 점도에서도 오히려 더 나은 안정함을 확인하였다.In order to confirm the stability of the formulation according to the emulsification system, the remaining content was fixed and an experiment was conducted whether or not a polyglyceryl-based surfactant was applied. As a result, as a result of confirming the first-day viscosities of Examples and Comparative Examples, despite the lower viscosity of Examples, formulation stability over time was confirmed. As a result, Examples were stable, but in Comparative Examples, oil and inorganic sunscreen were separated in the upper layer. phenomenon was found. As such, in the case of the examples, it was confirmed that rather better stability even at low viscosity.
<실험예 2. 실시예와 비교예의 소비자 만족도 비교><Experimental Example 2. Comparison of Customer Satisfaction between Examples and Comparative Examples>
실시예 및 비교예에서 얻은 각 시료에 대하여 25-40세 여성 20명으로 구성된 패널을 이용하여 사용감을 평가하였다. 이때, 평가항목은 도포시에 느껴지는 발림성, 밀착감, 유분감, 마무리감을 측정하는 것으로 하였으며 평가는 1점에서 5점까지 1점 단위로 하였고 매우 나쁨(1점), 나쁨(2점), 보통(3점), 좋음(4점), 아주 좋음(5점)으로 평가하였다. For each sample obtained in Examples and Comparative Examples, the feeling of use was evaluated using a panel consisting of 20 women aged 25 to 40 years. At this time, the evaluation items were to measure the spreadability, adhesion, oiliness, and finish felt during application, and the evaluation was made on a scale of 1 to 5, with very poor (1 point), bad (2 points), and average (3 points). points), good (4 points), and very good (5 points).
실시예와 비교예의 경우 실시예가 W/O 화장료의 특징인 밀착감은 기존과 동등한 수준이나 발림성과 유분감 및 마무리감에서도 더 나은 선호도를 보였다. In the case of Examples and Comparative Examples, the adhesion feeling, which is a characteristic of W / O cosmetics, was at the same level as the conventional one, but showed better preference in application, oily feeling, and finishing feeling.
Claims (9)
상기 폴리글리세릴 계열의 계면활성제는 리시놀레익애씨드의 폴리머와 폴리글리세린류의 복합에스터이고,
상기 비이온 계면활성제는 피이지-30 디폴리하이드록시스테아레이트를 포함하는, 자외선 차단용 화장료 조성물.It includes polyglyceryl-based surfactants, nonionic surfactants, inorganic sunscreens and organic sunscreens,
The polyglyceryl-based surfactant is a complex ester of a polymer of ricinoleic acid and polyglycerin,
The nonionic surfactant comprises PEG-30 dipolyhydroxystearate, a cosmetic composition for sunscreen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230040060A KR102678386B1 (en) | 2015-03-03 | 2023-03-27 | Sunscreen composition comprising polyglyceryl surfactants |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150030018A KR20160107064A (en) | 2015-03-03 | 2015-03-03 | Sunscreen composition comprising polyglyceryl surfactants |
| KR1020230040060A KR102678386B1 (en) | 2015-03-03 | 2023-03-27 | Sunscreen composition comprising polyglyceryl surfactants |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020150030018A Division KR20160107064A (en) | 2015-03-03 | 2015-03-03 | Sunscreen composition comprising polyglyceryl surfactants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20230047985A true KR20230047985A (en) | 2023-04-10 |
| KR102678386B1 KR102678386B1 (en) | 2024-06-24 |
Family
ID=56946575
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020150030018A KR20160107064A (en) | 2015-03-03 | 2015-03-03 | Sunscreen composition comprising polyglyceryl surfactants |
| KR1020230040060A KR102678386B1 (en) | 2015-03-03 | 2023-03-27 | Sunscreen composition comprising polyglyceryl surfactants |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020150030018A KR20160107064A (en) | 2015-03-03 | 2015-03-03 | Sunscreen composition comprising polyglyceryl surfactants |
Country Status (1)
| Country | Link |
|---|---|
| KR (2) | KR20160107064A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102639495B1 (en) * | 2023-11-28 | 2024-02-22 | 주식회사 부쉬맨 | Waterproof sunscreen composition |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102378545B1 (en) * | 2017-04-26 | 2022-03-23 | 주식회사 엘지생활건강 | Oil-in-water cosmetic emulsion comprising high content of internal oil phase |
| KR102464015B1 (en) * | 2017-11-20 | 2022-11-08 | (주)아모레퍼시픽 | Sun screening cometic composition comprising a polyglyceryl-based emulsifier and a sorbitan-based emulsifier |
| KR102392928B1 (en) * | 2021-11-11 | 2022-05-03 | (주)나우코스 | UV protection cosmetic composition with excellent stability without PEG-based emulsifier |
| WO2024111133A1 (en) | 2022-11-25 | 2024-05-30 | Lvmh Recherche | Liquid water-in-oil emulsion cosmetic composition |
| KR102683608B1 (en) * | 2023-11-29 | 2024-07-11 | 한국콜마주식회사 | Emulsion type cosmetic composition with dipersion composition comprising an inorganic uv blocking ingredients |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20110012942A (en) * | 2009-07-31 | 2011-02-09 | (주)아모레퍼시픽 | Cosmetic composition for uv protection |
-
2015
- 2015-03-03 KR KR1020150030018A patent/KR20160107064A/en not_active IP Right Cessation
-
2023
- 2023-03-27 KR KR1020230040060A patent/KR102678386B1/en active IP Right Grant
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20110012942A (en) * | 2009-07-31 | 2011-02-09 | (주)아모레퍼시픽 | Cosmetic composition for uv protection |
Non-Patent Citations (1)
| Title |
|---|
| 네이버 블로그 게시글,‘스킨푸드 선크림 6종 자차 성분 간단 리뷰’* * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102639495B1 (en) * | 2023-11-28 | 2024-02-22 | 주식회사 부쉬맨 | Waterproof sunscreen composition |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160107064A (en) | 2016-09-13 |
| KR102678386B1 (en) | 2024-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102678386B1 (en) | Sunscreen composition comprising polyglyceryl surfactants | |
| KR101551370B1 (en) | Cosmetic composition for uv-protecting prepared being impregnated in a sponge foam | |
| EP2823807B1 (en) | Sunscreen composition | |
| KR101002866B1 (en) | Water-in-oil emulsion-type cosmetic composition for blocking ultraviolet ray | |
| KR102005229B1 (en) | Oil in Water Type Macro Emulsion Cosmetic Composition for UV Protection | |
| KR20120065982A (en) | Uv blocking cosmetic composition prepared by being impregnated in urethane foam | |
| KR102284873B1 (en) | A Sunscreen Cosmetic Formulation with Increased UV absorption efficiency by UV light | |
| KR20090100643A (en) | Uv blocking cosmetic composition prepared by being impregnated in urethane foam | |
| KR20190057660A (en) | Sun screening cometic composition comprising a polyglyceryl-based emulsifier and a sorbitan-based emulsifier | |
| KR101798024B1 (en) | Transparent cosmetic composition having ultraviolet protection functions | |
| JP4866066B2 (en) | Cosmetics | |
| KR102498844B1 (en) | UV block cosmetic composition comprising high inorganic uv absorbers | |
| JP7350011B2 (en) | Shape memory sunscreen composition | |
| KR20110001539A (en) | Preparation of hollow spherical silica complex pigment containing organic uv agents and cosmetics composition for sunscreen thereof | |
| KR102211894B1 (en) | UV protection cosmetic composition comprising waterborne polyurethane | |
| KR101142233B1 (en) | Solid Formed Cosmetic Composition For Sunscreen And Manufacturing Method Thereof | |
| KR20110132294A (en) | Uv block cosmetic composition of powder type | |
| KR20190038789A (en) | Cosmetics of water insoluble sponge containing cosmetic compositions of sunscreen function | |
| KR100884480B1 (en) | Solid-type wax-free cosmetic composition for blocking ultraviolet ray | |
| EP3878519A1 (en) | Topical sun protection composition | |
| KR101542917B1 (en) | Cosmetics of water insoluble sponge containing cosmetic compositions of sunscreen function | |
| KR102413187B1 (en) | UV block cosmetic composition containing anionic surfactant and polymeric surfactant | |
| KR101776175B1 (en) | Sunscreen cosmetic composition having excellent durability | |
| KR102587916B1 (en) | Cosmetic composition of water-in-silicone type containing organic UV absorbers | |
| CN101998848B (en) | Sunscreen cosmetic powder material composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |